|
Indocyanine green (ICG) Clinical Trials
2 actively recruiting trials across 1 location
No change since May 2026
Pipeline
Phase 2: 1
Top Sponsors
- University of Aarhus1
- Medical University of South Carolina1
Indications
- Heart Disease1
- Turner Syndrome1
- Lymphedema1
- Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)1
- Cardiovascular Diseases1
Other1 trial
Charleston, South Carolina1 trial
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Medical University of South Carolina Hollings Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.